P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

May 2012

Features

Evaluation of an Adult Insulin Infusion Protocol At an Academic Medical Center

After a more lenient insulin protocol was implemented at the authors’ institution, patients’ blood glucose values stayed within the target range for a shorter time than with the former (stricter) protocol. Fewer episodes of hypoglycemia occurred with the newer protocol, but rates of severe hypoglycemia were similar with both protocols.
Katerina I. Petrov, PharmD; Tammy L. Burns, PharmD, BCPS; and Andjela Drincic, MD

Drug Use Evaluation of Moxifloxacin (Avelox) Using a Hand-Held Electronic Device At a Canadian Teaching Hospital

Seeking to determine whether moxifloxacin was being overused as a first-line therapy in the hospital, the authors found a high rate of appropriate use. Personal digital assistants (PDAs) were helpful, easy to use, and superior to paper methods in collecting data for their DUE review.
Jennifer A. E. Samilski, MD; Tim T. Y. Lau, PharmD, ACPR; Dean H. T. Elbe, PharmD, ACPR, BCPP; Amneet K. Aulakh, PharmD, ACPR; and Eric M. C. Lun, PharmD, ACPR

FDA Considers a New Paradigm For Over-the-Counter Medications

More Power—but More Burdens—for Pharmacists and Pharmacies

The FDA is debating whether to switch more prescription drugs to a new over-the-counter category and whether a drug could be classified as both a prescription and a nonprescription product. If the FDA approves this paradigm, pharmacists and pharmacies would have important roles to play.
Stephen Barlas

Meeting Highlights

2012 American College of Cardiology, 61st Annual Scientific Session & Expo

Topics include immediate-use glucose, insulin, and potassium for cardiac protection; vorapaxar to prevent atherothrombosis; and rivaroxaban for the treatment of pulmonary embolism. Interactions with dietary supplements are also reviewed.
Walter Alexander

Departments

Medication Errors

Managing Visits From Pharmaceutical Sales Representatives

Implementing policies for pharmaceutical sales representatives who visit hospitals
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Bar-Code Rule for Medical Devices May Be Imminent

Benefits and shortcomings of a national identification system for tracking medical devices
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Axitinib (Inlyta) for renal cell carcinoma; tafluprost (Zioptan) to reduce intraocular pressure; and lucinactant (Surfaxin) to prevent respiratory distress syndrome in premature infants
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Fidaxomicin (Dificid), a Novel Oral Macrocyclic Antibacterial Agent For the Treatment of Clostridium difficile–Associated Diarrhea in Adults

Fidaxomicin (Dificid) for Clostridium difficile–associated diarrhea
Martin Paspe Cruz, PharmD, CGP, BCPP